The effects of 4-aminopyridine and tetraethylammonium on the kinetics of transmitter release at the mammalian neuromuscular synapse.
The effect of 4-aminopyridine and tetraethylammonium on the time course of neurotransmitter release was examined at the neuromuscular junction using a computer-aided method which directly measured the time of occurrence of individual quanta. It is apparent that the action of 4-aminopyridine, at concentrations of 0.1 to 1 mM, when examined in isolation from other experimental manipulations, is to cause a greatly enhanced probability of release at times subsequent to the time over which the initial phase is essentially unchanged, i.e., there is no evidence of an increased latency of release caused by 4-aminopyridine. Similar results were obtained with tetraethylammonium, although the prolongation of release was much less, even at a concentration of 1 mM. The results are consistent with the view that the predominant action of 4-aminopyridine is to block the potassium conductance responsible for repolarization of the action potential and hence cause a prolonged Ca2+ current. The action of tetraethylammonium is consistent with the block of a different K+ conductance, with consequent enhancement of action potential effectiveness, but with little prolongation of release. The observation of multiple peaks, or oscillations in the release probability function at high (ca. 1 mM) concentrations of 4-aminopyridine, may be related, as is suggested, to oscillations of presynaptic membrane potential, or perhaps to changes in the electrochemical gradient for Ca2+ influx.
Saint
D A
DA
Department of Physiology, John Curtin School of Medical Research, Australian National University, Canberra, A.C.T.
D015761:4-Aminopyridine / Q000494:pharmacology*; D000818:Animals; D066298:In Vitro Techniques; D007700:Kinetics; D051379:Mice; D009045:Motor Endplate / Q000187:drug effects; D009469:Neuromuscular Junction / Q000187:drug effects* / Q000378:metabolism; D018377:Neurotransmitter Agents / Q000378:metabolism*; D013569:Synapses / Q000187:drug effects / Q000378:metabolism*; D013757:Tetraethylammonium Compounds / Q000494:pharmacology*
D018377:Neurotransmitter Agents; D013757:Tetraethylammonium Compounds; D015761:4-Aminopyridine